Skip to content

Efficacy of myopia control and influence on visual performance in children treated with Orthokeratology using increased compression factor

Efficacy of myopia control and influence on visual performance in children treated with Orthokeratology using increased compression factor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072008
Enrollment
Unknown
Registered
2023-05-31
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Control grouo:Subjects will be fitted with + 0.75D conventional compression factor orthokeratology lenses.
Test Group:Subjects will be fitted with + 0.75D conventional compression factor orthokeratology lenses.

Sponsors

West China hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: (1) Age between 8 and 12 years old. (2) The best corrected visual acuity in a single eye is no worse than 20/25. (3) Spherical refractive error between -4.00 D and -0.75 D. (4) Corneal astigmatism <= 1.50D, axis at 180±30, subjective refraction astigmatism <= 1.50D. (5) Anisometropia <= 1.00D. (6) No history of myopia control treatment, no history of wearing contact lenses. (7) Able to attend regular follow-up visits to West China Hospital until the lenses have been worn for 12 months. (8) Sleep no less than 8 hours per night, wear lens at least 6 nights per week. (9) Clear optical structure in the examined eye. (10) No nystagmus in the examined eye and good fixation ability (11) Corneal curvature (examined by keratometer) between 39.50 D and 45.00 D.

Exclusion criteria

Exclusion criteria: (1) Single eye meet the inclusion criteria. (2) Suffering from systemic diseases that may affect the eye, such as diabetes, Down's syndrome, hyperthyroidism, rheumatoid arthritis, or other conditions that researchers consider unacceptable for ortho-k lenses. (3) Suffering from ocular disorders that may affect the fitting of ortho-k lens: e.g., vernal keratoconjunctivitis, dry eye disorder (BUT <5s), etc. (4) Suffering from strabismus. (5) Patients who are on or require drugs during the study period that may cause dry eye or affect visual acuity and corneal curvature, etc. (immunosuppressants, glucocorticoids, IOP-lowering medication, low concentrations of atropine). (6) Those who have a history of internal eye surgery. (7) Patients with abnormal intraocular pressure (normal IOP range is 10-21 mmHg, and the difference in bilateral IOP should be =5 mmHg). (8) Those who participated in other drug clinical trials within 90 days prior to screening, and those who participated in other medical device clinical trials within 30 days. (9) Those who cannot be followed up as prescribed by the researchers. (10) Patients whose examination results suggest contraindications to fitting or unsuitability for fitting ortho-k lenses. (11) Other conditions that the researchers consider unsuitable to participate in.

Design outcomes

Primary

MeasureTime frame
Axial length;

Secondary

MeasureTime frame
Visual acuity;Objective refraction;Subjective refraction;Aberration;Specular microscope;Retinal peripheral defocus;Choroidal thickness;Vision-related questionnaire;

Countries

China

Contacts

Public ContactWei Ma

West China Hospital, Sichuan University

18038862@qq.com+86 181 1315 1618

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026